bpc 157 sciatica clinical trial BPC-157: Disc Herniation & Lower Back Pain: Canadian Guide Sciatica | New England Journal
Description
Reduced effectiveness: If your typical dose seems less effective than previous weeks from the same vial, potency may have decreased
Full tissue-level changes take longer, but they build with consistency
Without controlled body composition measurements, it's hard to interpret anecdotal reports
This is one of the less-discussed but potentially significant risks of routinely using degraded peptide medications
CJC-1295 and Ipamorelin stimulate endogenous HGH release, while AOD-9604 targets fat directly without affecting IGF-1. This dual action can accelerate fat loss and body recomposition
